Teru Kanda

4.8k total citations · 1 hit paper
72 papers, 3.8k citations indexed

About

Teru Kanda is a scholar working on Oncology, Epidemiology and Molecular Biology. According to data from OpenAlex, Teru Kanda has authored 72 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 22 papers in Epidemiology and 18 papers in Molecular Biology. Recurrent topics in Teru Kanda's work include Viral-associated cancers and disorders (48 papers), Cytomegalovirus and herpesvirus research (21 papers) and Lymphoma Diagnosis and Treatment (17 papers). Teru Kanda is often cited by papers focused on Viral-associated cancers and disorders (48 papers), Cytomegalovirus and herpesvirus research (21 papers) and Lymphoma Diagnosis and Treatment (17 papers). Teru Kanda collaborates with scholars based in Japan, United States and France. Teru Kanda's co-authors include Geoffrey M. Wahl, Kevin F. Sullivan, Kenzo Takada, Misako Yajima, Takayuki Murata, Tatsuya Tsurumi, Dai Iwakiri, Tomohiro Tamura, Seiji Maruo and Hiroki Isomura and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Teru Kanda

71 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Histone–GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells

1998 812 citations Teru Kanda, Kevin F. Sullivan et al. Current Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Teru Kanda Japan	35	1.8k	1.8k	906	739	549	72	3.8k
Päivi M. Ojala Finland	30	1.4k 0.8×	1.4k 0.8×	756 0.8×	315 0.4×	292 0.5×	60	2.8k
Mila Janković United States	39	1.2k 0.7×	3.1k 1.8×	647 0.7×	3.1k 4.2×	463 0.8×	59	6.3k
James C. Neil United Kingdom	38	754 0.4×	2.0k 1.1×	926 1.0×	794 1.1×	190 0.3×	97	3.8k
Miranda Thomas Italy	33	2.4k 1.3×	2.5k 1.4×	2.4k 2.7×	694 0.9×	312 0.6×	70	5.2k
Friedrich A. Grässer Germany	31	1.2k 0.7×	3.5k 2.0×	965 1.1×	736 1.0×	271 0.5×	54	5.3k
Pedro A. Lazo Spain	41	1.1k 0.6×	3.1k 1.7×	467 0.5×	665 0.9×	264 0.5×	144	4.6k
John A. Martignetti United States	38	786 0.4×	3.0k 1.7×	1.2k 1.4×	441 0.6×	194 0.4×	102	5.4k
Angus C. Wilson United States	34	689 0.4×	1.4k 0.8×	1.5k 1.7×	702 0.9×	109 0.2×	67	3.0k
Joe S. Mymryk Canada	38	1.3k 0.8×	2.8k 1.6×	589 0.7×	732 1.0×	129 0.2×	152	4.3k
Jean–Claude Weill France	43	699 0.4×	2.9k 1.7×	479 0.5×	4.0k 5.4×	556 1.0×	101	6.9k

Countries citing papers authored by Teru Kanda

Since Specialization

Citations

This map shows the geographic impact of Teru Kanda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teru Kanda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teru Kanda more than expected).

Fields of papers citing papers by Teru Kanda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teru Kanda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teru Kanda. The network helps show where Teru Kanda may publish in the future.

Co-authorship network of co-authors of Teru Kanda

This figure shows the co-authorship network connecting the top 25 collaborators of Teru Kanda. A scholar is included among the top collaborators of Teru Kanda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teru Kanda. Teru Kanda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kiso, Maki, Seiya Yamayoshi, Yoshiki Yamaguchi, et al.. (2025). G-quadruplex-forming small RNA inhibits coronavirus and influenza A virus replication. Communications Biology. 8(1). 27–27.

Okuno, Yusuke, Yohei Narita, H. M. Abdullah Al Masud, et al.. (2021). RNAseq analysis identifies involvement of EBNA2 in PD-L1 induction during Epstein-Barr virus infection of primary B cells. Virology. 557. 44–54. 20 indexed citations

Abé, Hiroyuki, Akiko Kunita, Teru Kanda, et al.. (2019). Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein–Barr Virus-associated gastric carcinoma. PLoS ONE. 14(1). e0211358–e0211358. 37 indexed citations

Sugimoto, Atsuko, Yoriko Yamashita, Teru Kanda, Takayuki Murata, & Tatsuya Tsurumi. (2019). Epstein-Barr virus genome packaging factors accumulate in BMRF1-cores within viral replication compartments. PLoS ONE. 14(9). e0222519–e0222519. 8 indexed citations

Kanda, Teru. (2018). EBV-Encoded Latent Genes. Advances in experimental medicine and biology. 1045. 377–394. 59 indexed citations

Kanda, Teru, Yuki Furuse, Hitoshi Oshitani, & Tohru Kiyono. (2016). Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains. Journal of Virology. 90(9). 4383–4393. 55 indexed citations

Narita, Yohei, Atsuko Sugimoto, Daisuke Kawashima, et al.. (2015). A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis. Scientific Reports. 5(1). 11767–11767. 8 indexed citations

Kanda, Teru, Toshiki Ochi, Hiroshi Fujiwara, et al.. (2012). HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system. Cancer Gene Therapy. 19(8). 566–571. 1 indexed citations

Murata, Takayuki, Shinichi Saito, Daisuke Kawashima, et al.. (2011). Involvement of Jun Dimerization Protein 2 (JDP2) in the Maintenance of Epstein-Barr Virus Latency. Journal of Biological Chemistry. 286(25). 22007–22016. 24 indexed citations

10.

Noguchi, Kohji, Masafumi Minoshima, Gengo Kashiwazaki, et al.. (2011). DNA ligand designed to antagonize EBNA1 represses Epstein–Barr virus‐induced immortalization. Cancer Science. 102(12). 2221–2230. 18 indexed citations

11.

Iwahori, Satoko, Takayuki Murata, Ayumi Kudoh, et al.. (2009). Phosphorylation of p27Kip1 by Epstein-Barr Virus Protein Kinase Induces Its Degradation through SCFSkp2 Ubiquitin Ligase Actions during Viral Lytic Replication. Journal of Biological Chemistry. 284(28). 18923–18931. 24 indexed citations

12.

Nakayama, Sanae, Takayuki Murata, Kazutaka Murayama, et al.. (2009). Epstein-Barr Virus Polymerase Processivity Factor Enhances BALF2 Promoter Transcription as a Coactivator for the BZLF1 Immediate-Early Protein. Journal of Biological Chemistry. 284(32). 21557–21568. 20 indexed citations

13.

Murata, Takayuki, Hiroki Isomura, Yoriko Yamashita, et al.. (2009). Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase. Virology. 389(1-2). 75–81. 49 indexed citations

14.

Uchino, Keiro, Morikazu Imamura, Katsuhiko Shimizu, Teru Kanda, & Tomohiro Tamura. (2007). Germ line transformation of the silkworm, Bombyx mori, using the transposable element Minos. Molecular Genetics and Genomics. 277(3). 213–220. 33 indexed citations

15.

Ahsan, Nazmul, Teru Kanda, Kazuo Nagashima, & Kenzo Takada. (2005). Epstein-Barr Virus Transforming Protein LMP1 Plays a Critical Role in Virus Production. Journal of Virology. 79(7). 4415–4424. 57 indexed citations

16.

Sahara, Ken, Hisanori Bando, Katsura Kojima, et al.. (2003). Use of RNAi technology to confer enhanced resistance to BmNPV on transgenic silkworms. Archives of Virology. -1(1). 1–1. 66 indexed citations

17.

Quan, Guoxing, Teru Kanda, & Tomohiro Tamura. (2002). Induction of the white egg 3 mutant phenotype by injection of the double‐stranded RNA of the silkworm white gene. Insect Molecular Biology. 11(3). 217–222. 96 indexed citations

18.

Kanda, Teru, et al.. (2001). Coupling of Mitotic Chromosome Tethering and Replication Competence in Epstein-Barr Virus-Based Plasmids. Molecular and Cellular Biology. 21(10). 3576–3588. 82 indexed citations

19.

Kanda, Teru, Kevin F. Sullivan, & Geoffrey M. Wahl. (1998). Histone–GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Current Biology. 8(7). 377–385. 812 indexed citations breakdown →

20.

Kanda, Teru, D Bunnag, Somjai Leemingsawat, et al.. (1995). Integration of control measures for malaria vectors in endemic areas of Thailand.. PubMed. 26(1). 154–63. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact